| Dr Gary L Cesar, DPM | |
|
1515 Lake Lansing Rd, Lansing, MI 48912-3752 | |
| (517) 487-5171 | |
| (517) 371-1366 |
| Full Name | Dr Gary L Cesar |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 39 Years |
| Location | 1515 Lake Lansing Rd, Lansing, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053395970 | NPI | - | NPPES |
| 3012355 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | GC001360 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Edward W Sparrow Hospital | Lansing, MI | Hospital |
| Provider Name | Gary L Cesar Dpm Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1992975064 PECOS PAC ID: 8123273901 Enrollment ID: O20130228000035 |
News Archive
Researchers from Belgium and Germany demonstrated how the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is fine-tuned towards the temperature and protease conditions of the human airways, which in turn enhances viral transmission and subsequent pathology. Their study is available on the bioRxiv* preprint server.
Scientists have created a tool for mopping up the clumps of mutant protein that drive neurodegeneration in Huntington's disease. Emory University researchers engineered a virus to make an intracellular antibody or "intrabody" against huntingtin, the protein whose mutant forms poison the brain cells of people with Huntington's.
Romark Laboratories announced that it has entered into a strategic agreement with Lupin Limited and its subsidiaries (collectively Lupin) designed to expand promotion and distribution efforts related to its Alinia (nitazoxanide) for Oral Suspension, 100 mg/5 mL. Under the agreement, Lupin acquired an exclusive license to promote and distribute Alinia for Oral Suspension in the United States.
A first-of-its-kind drug targeting a fused gene found in many types of cancer was effective in 93 percent of pediatric patients tested, researchers at UT Southwestern's Simmons Cancer Center announced.
I've proposed a balanced approach that looks at the entire budget for savings. The third step is to reduce the growth in health care spending in order to strengthen Medicare and Medicaid for future generations. We will get rid of wasteful subsidies and fraud that cost Medicare billions of dollars each year. We'll cut spending on prescription drugs by helping to get generic brands of medicine to market faster.
› Verified 1 days ago
| Provider Name | Compass Healthcare Plc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1932533692 PECOS PAC ID: 6002045895 Enrollment ID: O20140127000294 |
News Archive
Researchers from Belgium and Germany demonstrated how the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is fine-tuned towards the temperature and protease conditions of the human airways, which in turn enhances viral transmission and subsequent pathology. Their study is available on the bioRxiv* preprint server.
Scientists have created a tool for mopping up the clumps of mutant protein that drive neurodegeneration in Huntington's disease. Emory University researchers engineered a virus to make an intracellular antibody or "intrabody" against huntingtin, the protein whose mutant forms poison the brain cells of people with Huntington's.
Romark Laboratories announced that it has entered into a strategic agreement with Lupin Limited and its subsidiaries (collectively Lupin) designed to expand promotion and distribution efforts related to its Alinia (nitazoxanide) for Oral Suspension, 100 mg/5 mL. Under the agreement, Lupin acquired an exclusive license to promote and distribute Alinia for Oral Suspension in the United States.
A first-of-its-kind drug targeting a fused gene found in many types of cancer was effective in 93 percent of pediatric patients tested, researchers at UT Southwestern's Simmons Cancer Center announced.
I've proposed a balanced approach that looks at the entire budget for savings. The third step is to reduce the growth in health care spending in order to strengthen Medicare and Medicaid for future generations. We will get rid of wasteful subsidies and fraud that cost Medicare billions of dollars each year. We'll cut spending on prescription drugs by helping to get generic brands of medicine to market faster.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gary L Cesar, DPM 1515 Lake Lansing Rd, Lansing, MI 48912-3752 Ph: (517) 487-5171 | Dr Gary L Cesar, DPM 1515 Lake Lansing Rd, Lansing, MI 48912-3752 Ph: (517) 487-5171 |
News Archive
Researchers from Belgium and Germany demonstrated how the spike glycoprotein of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is fine-tuned towards the temperature and protease conditions of the human airways, which in turn enhances viral transmission and subsequent pathology. Their study is available on the bioRxiv* preprint server.
Scientists have created a tool for mopping up the clumps of mutant protein that drive neurodegeneration in Huntington's disease. Emory University researchers engineered a virus to make an intracellular antibody or "intrabody" against huntingtin, the protein whose mutant forms poison the brain cells of people with Huntington's.
Romark Laboratories announced that it has entered into a strategic agreement with Lupin Limited and its subsidiaries (collectively Lupin) designed to expand promotion and distribution efforts related to its Alinia (nitazoxanide) for Oral Suspension, 100 mg/5 mL. Under the agreement, Lupin acquired an exclusive license to promote and distribute Alinia for Oral Suspension in the United States.
A first-of-its-kind drug targeting a fused gene found in many types of cancer was effective in 93 percent of pediatric patients tested, researchers at UT Southwestern's Simmons Cancer Center announced.
I've proposed a balanced approach that looks at the entire budget for savings. The third step is to reduce the growth in health care spending in order to strengthen Medicare and Medicaid for future generations. We will get rid of wasteful subsidies and fraud that cost Medicare billions of dollars each year. We'll cut spending on prescription drugs by helping to get generic brands of medicine to market faster.
› Verified 1 days ago
Mid-michigan Podiatry, Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1540 Lake Lansing Rd, Suite 102, Lansing, MI 48912 Phone: 517-913-3855 Fax: 517-913-4020 | |
John David Johnson, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3401 E Saginaw St, Suite 111, Lansing, MI 48912 Phone: 517-351-7640 Fax: 517-351-9462 | |
7stines Podiatry Center,pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 701 Snow Rd, Suite C, Lansing, MI 48917 Phone: 517-323-8333 Fax: 517-323-8333 | |
Foremost Podiatry, P.c. Podiatrist Medicare: Medicare Enrolled Practice Location: 3390 E Jolly Rd, Lansing, MI 48910 Phone: 517-882-8673 Fax: 517-882-3935 | |
Douglas Philip Johnson, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3401 E Saginaw St, Ste 111, Lansing, MI 48912 Phone: 517-351-7640 Fax: 517-351-9462 | |
Dr. Michael Dziewit Jr., D.P.M Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3390 E Jolly Rd, Lansing, MI 48910 Phone: 561-882-8673 Fax: 517-882-3935 |